Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Bowman capsule rupture in children with myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis predicts poor renal survival: Pei Zhang, Li-li Jia, Meng-zhen Fu, Kai-li Shi, Chun-lin Gao, Zheng-kun Xia; Received March 6, 2023 Accepted May 25, 2023 Published online November 1, 2023; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Clinical features and outcomes of elderly patients with antineutrophil cytoplasmic antibody-positive vasculitis: a single-center retrospective study: Hyo Jin Kim, Miyeun Han, Sang Heon Song, Eun Young Seong; Kidney Res Clin Pract. 2022;41(2):209-218. Published online November 16, 2021; DOI: https://doi.org/10.23876/j.krcp.21.008
Web of Science 2 Cited By 2; Full text PubReader ePub PDF Supplementary Material

A Case of Idiopathic Retroperitoneal Fibrosis Associated with Rapidly Progressive Glomerulonephritis with Anti-myeloperoxidase Antineutrophil Cytoplasmic Antibodies: Yu-Ji Lee, M.D., Hae Won Jung, M.D., Jung Eun Lee, M.D., Wooseong Huh, M.D., Dae Joong Kim, M.D., Ha Young Oh, M.D. and Yoon Goo Kim, M.D.; Korean J Nephrol. 2009;28(3):248-252.; PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

14,886	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,844	C4d Puzzle in ABO-incompatible kidney transplantation
8,308	How should we treat acute kidney injury caused by renal congestion?
13,035	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,064	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.